Benjamin P. Linas, MD

Associate Professor, Medicine

Benjamin Linas
617.414.5238

Biography

Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.

Other Positions

  • Associate Professor, Epidemiology, Boston University School of Public Health

Education

  • New York University School of Medicine, MD
  • Harvard School of Public Health, MPH
  • Yale University, BA

Publications

  • Published on 9/17/2018

    Leech AA, Burgess JF, Sullivan M, Kuohung W, HornĂ½ M, Drainoni ML, Christiansen CL, Linas BP. Cost-effectiveness of pre-exposure prophylaxis for HIV prevention for conception in the United States. AIDS. 2018 Sep 17. PMID: 30234602.

    Read at: PubMed
  • Published on 8/30/2018

    Shelton BA, Sawinski D, Linas BP, Reese PP, Mustian M, Hungerpiller M, Reed RD, MacLennan PA, Locke JE. Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation. Am J Transplant. 2018 Oct; 18(10):2483-2495. PMID: 30058218.

    Read at: PubMed
  • Published on 8/28/2018

    Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, Linas BP. Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care. J Pediatr. 2018 Aug 28. PMID: 30170857.

    Read at: PubMed
  • Published on 8/1/2018

    Wurcel AG, Burke DJ, Wang JJ, Engle B, Noonan K, Knox TA, Kim AY, Linas BP. The Burden of Untreated HCV Infection in Hospitalized Inmates: a Hospital Utilization and Cost Analysis. J Urban Health. 2018 Aug; 95(4):467-473. PMID: 30027427.

    Read at: PubMed
  • Published on 8/1/2018

    Barocas JA, Tasillo A, Eftekhari Yazdi G, Wang J, Vellozzi C, Hariri S, Isenhour C, Randall L, Ward JW, Mermin J, Salomon JA, Linas BP. Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States. Clin Infect Dis. 2018 Aug 01; 67(4):549-556. PMID: 29420742.

    Read at: PubMed
  • Published on 7/1/2018

    Linas BP. Commentary on Bansback et al. (2018): Estimating the cost of stigma against injection. Addiction. 2018 Jul; 113(7):1274-1275. PMID: 29883035.

    Read at: PubMed
  • Published on 6/1/2018

    Chow FC, Wilson MR, Wu K, Ellis RJ, Bosch RJ, Linas BP. Stroke incidence is highest in women and non-Hispanic blacks living with HIV in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort. AIDS. 2018 Jun 01; 32(9):1125-1135. PMID: 29746317.

    Read at: PubMed
  • Published on 6/1/2018

    Linas BP, Nolen S. A Guide to the Economics of Hepatitis C Virus Cure in 2017. Infect Dis Clin North Am. 2018 06; 32(2):447-459. PMID: 29778265.

    Read at: PubMed
  • Published on 5/31/2018

    Schechter-Perkins EM, Miller NS, Hall J, Hartman JJ, Dorfman DH, Andry C, Linas BP. Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt-out Hepatitis C Virus Screening Program. Acad Emerg Med. 2018 May 31. PMID: 29851238.

    Read at: PubMed
  • Published on 5/1/2018

    Rodriguez CV, Rubenstein KB, Linas B, Hu H, Horberg M. Increasing hepatitis C screening in a large integrated health system: science and policy in concert. Am J Manag Care. 2018 May 01; 24(5):e134-e140. PMID: 29851444.

    Read at: PubMed

View 59 more publications: View full profile at BUMC

View all profiles